# Deferasirox

NDC: 67877-554
Generic name: Deferasirox
Labeler / Manufacturer: Ascend Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200401

FDA application: ANDA210555

## Active ingredients

- DEFERASIROX: 360 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67877-554"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67877-554
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0fb210b3-6a3d-4313-83ce-52012e384f9b